A new investigation published in the journal Neuropharmacology offers a nuanced perspective on the popular practice of ...

In April, Vail Health’s Behavioral Health Innovation Center will kick off the second of two studies aimed at targeting depression. The OPTIMIZE study will examine the impacts of psilocybin, the active ...

Psilocybin—the psychedelic compound that occurs naturally in certain "magic" mushroom species—has been shown in trials to provide long-term treatment for depression and anxiety. But the chemical's ...

Psilocybin, the active psychedelic ingredient in magic mushrooms, has been proven to impact patients with depression positively. Vail Health’s OPTIMIZE study, which will administer doses of psilocybin ...

Unsupervised use of psilocybin, or “magic mushrooms,” has accelerated among all age groups in the United States, but especially among adolescents and people 30 and older, a new study found. “The ...

This is a small study, and scientists still need to conduct more research to understand the longterm effects of psilocybin. Psilocybin is the active ingredient in magic mushrooms. In recent decades, ...

LONDON, July 25, 2023 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (CMPS) (“COMPASS”), a biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health, today ...

Richard Schaefer took part in a clinical trial of psilocybin as a treatment for addiction. (Photo courtesy of Richard Schaefer) It was a day like any other when Richard Schaefer entered a Madison ...

PORTLAND, Ore. — For the first time, a scientific study has examined Oregon's pioneering model for psilocybin therapy, reflecting on a program now two years underway. Psilocybin is the psychedelic ...

Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019, according to a new study led by researchers at the ...